See All Slides - tctmd.com

Slides

Presentation TCT 2013

How to Recognize Artifacts and Avoid Mistakes

Presenter: Soo-Jin Kang

October 30, 2013

Presentation TCT 2013

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

Presenter: Patrick Serruys

October 30, 2013

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

FFR in Patients with Acute Coronary Syndromes

Presenter: Habib Samady

October 30, 2013

Presentation TCT 2013

Patient Selection Overview: Understanding the STS Risk Score, Patient Risks, and Individual High-Risk Characteristics for Surgery

Presenter: Patrick McCarthy

October 30, 2013

Presentation TCT 2013

Understanding the FDA Panel Decision to Approve MitraClip

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

JCAHO in the Cath Lab

Presenter: Bernadette Speiser

October 30, 2013

Presentation TCT 2013

Translational Perspectives: Moving Beyond RDN Therapies: Potential Targets, Experimental Models and Translational Strategies

Presenter: Todd Brinton

October 30, 2013

Presentation TCT 2013

Con: A Risky and Unnecessary Approach!

Presenter: Cindy Grines

October 30, 2013

Presentation TCT 2013

Case IV: IVUS for Intermediate Left Main Lesions

Presenter: Soo-Jin Kang

October 30, 2013

Advertisement

Slides

How to Recognize Artifacts and Avoid Mistakes

The Great Debate: Does It Make Sense to Search and Destroy Focal Vulnerable Plaque? Yes! We Can Do This Safely, and It Will Save Lives and Prevent ACS!

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

FFR in Patients with Acute Coronary Syndromes

Patient Selection Overview: Understanding the STS Risk Score, Patient Risks, and Individual High-Risk Characteristics for Surgery

Understanding the FDA Panel Decision to Approve MitraClip

JCAHO in the Cath Lab

Translational Perspectives: Moving Beyond RDN Therapies: Potential Targets, Experimental Models and Translational Strategies

Con: A Risky and Unnecessary Approach!

Case IV: IVUS for Intermediate Left Main Lesions

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content